ALISHA MARCHETTI: Open Payments
NPI 1154658839 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 31 payments from 12 companies in 2025. Trend: 2023 $712 · 2024 $909 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $187 |
| Janssen Biotech, Inc. | 2 | $104 |
| Tempus AI, Inc | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Teleflex LLC | 3 | $69 |
| Novo Nordisk Inc | 2 | $63 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $33 |
| COLOPLAST CORP | 2 | $33 |
| Blue Earth Diagnostics | 1 | $26 |
Products named: ORGOVYX, ERLEADA, XT CDX, Nubeqa, Rivfloza, BARRIGEL, ADSTILADRIN, GEMTESA.
Industry payments across AZ — which companies pay providers there.
